Latest News
Tempus AI, Inc.
- Tempus AI secures multi-year data deal with Bristol Myers By Investing.com
- Form 8K Tempus AI Inc For: 23 October By Investing.com
- Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development
- Tempus AI Expands Strategic Collaborations to Drive Future Growth
- Could You Have Seen The Run In Tempus AI Stock Coming?
- Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?
- FDA Clears Tempus AI Tool to Detect Mitral Regurgitation From ECGs
- Tempus AI CEO Ryan Fukushima sells $49,000 in stock By Investing.com
- Form 144 Tempus AI For: 27 September By Investing.com
- Leica Biosystems brings Tempus pathology products to Aperio AI Store, accelerating AI-powered capabilities for oncology research
- Tempus AI Inc Stock (TEM) Closed Up by 7.38% on Sep 24: What Investors Need To Know
- Leica Biosystems Adds Tempus Oncology AI Tools to Aperio AI Store
Headlines from the last 30 days, linking to the original publishers. See all market news →